Načítá se...
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Gliclazide has been considered metabolized by CYP2C9. Its modified release formulation, gliclazide MR, shows low pharmacokinetic variability in Whites but high variability in Chinese. WHAT THIS STUDY ADDS: The results of this study show that the pharmacokine...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Science Inc
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000619/ https://ncbi.nlm.nih.gov/pubmed/17298483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02846.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|